Report Detail
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Insights, Forecast to 2025
- RnM3363338 |
- 29 April, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.
The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in these regions.
This research report categorizes the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market by top players/brands, region, type and end user. This report also studies the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Market size by Product
Immune DTaP Vaccine
Therapy DTaP Vaccine
Market size by End User
Adult
Pediatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Product
- 1.4.2 Immune DTaP Vaccine
- 1.4.3 Therapy DTaP Vaccine
- 1.5 Market by End User
- 1.5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Pediatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size
- 2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue 2014-2025
- 2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2014-2025
- 2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Growth Rate by Regions
- 2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions
- 2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
- 3.1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
- 3.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers
- 3.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturers
- 3.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Product
- 4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Product
- 4.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
- 6.1.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
- 6.1.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
- 6.3 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
7 Europe
- 7.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
- 7.1.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
- 7.1.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
- 7.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
- 8.1.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
- 8.1.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
- 8.3 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
9 Central & South America
- 9.1 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
- 9.1.1 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
- 9.1.2 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
- 9.3 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Countries
- 10.1.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Product
- 10.3 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by End User
11 Company Profiles
- 11.1 Sanofi Pasteur
- 11.1.1 Sanofi Pasteur Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.1.5 Sanofi Pasteur Recent Development
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.2.5 GlaxoSmithKline Recent Development
- 11.3 Protein Sciences Corporation
- 11.3.1 Protein Sciences Corporation Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.3.5 Protein Sciences Corporation Recent Development
- 11.4 Novartis AG
- 11.4.1 Novartis AG Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.4.5 Novartis AG Recent Development
- 11.5 Seqirus
- 11.5.1 Seqirus Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.5.5 Seqirus Recent Development
- 11.6 Merck Sharp & Dohme Corp
- 11.6.1 Merck Sharp & Dohme Corp Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.6.5 Merck Sharp & Dohme Corp Recent Development
- 11.7 Astellas Pharma US, Inc
- 11.7.1 Astellas Pharma US, Inc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.7.5 Astellas Pharma US, Inc Recent Development
- 11.8 Pfizer Inc
- 11.8.1 Pfizer Inc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.8.5 Pfizer Inc Recent Development
- 11.9 Johnson & Johnson
- 11.9.1 Johnson & Johnson Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.9.5 Johnson & Johnson Recent Development
- 11.10 Lanzhou Institute of Biological Products Co., Ltd
- 11.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Products Offered
- 11.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
- 11.11 AstraZeneca
- 11.12 Emergent BioSolutions Inc
12 Future Forecast
- 12.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast by Regions
- 12.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast by Product
- 12.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast by End User
- 12.4 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
- 12.5 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
- 12.6 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
- 12.7 Central & South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
- 12.8 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine . Industry analysis & Market Report on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine is a syndicated market report, published as Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
